These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 2549200
1. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells. Lee NH, el-Fakahany EE. J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200 [Abstract] [Full Text] [Related]
2. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions. Lee NH, el-Fakahany EE. J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516 [Abstract] [Full Text] [Related]
3. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Ellis J, Huyler J, Brann MR. Biochem Pharmacol; 1991 Oct 24; 42(10):1927-32. PubMed ID: 1741770 [Abstract] [Full Text] [Related]
4. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses. Lee NH, Fryer AD, Forray C, el-Fakahany EE. J Pharmacol Exp Ther; 1989 Dec 24; 251(3):992-9. PubMed ID: 2557423 [Abstract] [Full Text] [Related]
5. On the interaction of gallamine with muscarinic receptor subtypes. Michel AD, Delmendo RE, Lopez M, Whiting RL. Eur J Pharmacol; 1990 Jul 03; 182(2):335-45. PubMed ID: 2397745 [Abstract] [Full Text] [Related]
6. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J, Brown JH. Mol Pharmacol; 1983 Jul 03; 24(1):15-22. PubMed ID: 6135150 [Abstract] [Full Text] [Related]
7. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity. Tränkle C, Kostenis E, Mohr K. Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug 03; 364(2):172-8. PubMed ID: 11534857 [Abstract] [Full Text] [Related]
8. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. Kenakin T, Boselli C. J Pharmacol Exp Ther; 1989 Sep 03; 250(3):944-52. PubMed ID: 2778720 [Abstract] [Full Text] [Related]
9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE. Mol Pharmacol; 1986 Jul 03; 30(1):58-68. PubMed ID: 3755217 [Abstract] [Full Text] [Related]
10. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine. Waelbroeck M, Robberecht P, De Neef P, Christophe J. J Recept Res; 1988 Jul 03; 8(6):787-808. PubMed ID: 3193402 [Abstract] [Full Text] [Related]
11. Gallamine exerts biphasic allosteric effects at muscarinic receptors. Ellis J, Seidenberg M. Mol Pharmacol; 1989 Feb 03; 35(2):173-6. PubMed ID: 2918854 [Abstract] [Full Text] [Related]
12. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts. Schröter A, Tränkle C, Mohr K. Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec 03; 362(6):512-9. PubMed ID: 11138843 [Abstract] [Full Text] [Related]
13. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors. Surichamorn W, Kim ON, Lee NH, Lai WS, el-Fakahany EE. Neurochem Res; 1988 Dec 03; 13(12):1183-91. PubMed ID: 3237310 [Abstract] [Full Text] [Related]
14. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. McKinney M, Stenstrom S, Richelson E. Mol Pharmacol; 1985 Feb 03; 27(2):223-35. PubMed ID: 2982089 [Abstract] [Full Text] [Related]
15. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. Ehlert FJ. J Pharmacol Exp Ther; 1988 Nov 03; 247(2):596-602. PubMed ID: 3183955 [Abstract] [Full Text] [Related]
16. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors. Gillard M, Waelbroeck M, Christophe J. J Recept Res; 1986 Nov 03; 6(1):47-61. PubMed ID: 3754901 [Abstract] [Full Text] [Related]
17. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation. McKinney M, Stenstrom S, Richelson E. Mol Pharmacol; 1984 Sep 03; 26(2):156-63. PubMed ID: 6148690 [Abstract] [Full Text] [Related]
18. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors. Tränkle C, Weyand O, Schröter A, Mohr K. Mol Pharmacol; 1999 Nov 03; 56(5):962-5. PubMed ID: 10531401 [Abstract] [Full Text] [Related]
19. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors. Franken C, Tränkle C, Mohr K. Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb 03; 361(2):107-12. PubMed ID: 10685864 [Abstract] [Full Text] [Related]
20. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state. Narayanan TK, Aronstam RS. Neurochem Res; 1986 Oct 03; 11(10):1397-406. PubMed ID: 3785535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]